CN Patent

CN101941990B — 哌嗪和取代的哌啶抗病毒药物的前药

Assigned to Bristol Myers Squibb Co · Expires 2012-04-25 · 14y expired

What this patent protects

本发明提供用于制备前药化合物(I)的中间体化合物Ic和Icb。

USPTO Abstract

本发明提供用于制备前药化合物(I)的中间体化合物Ic和Icb。

Drugs covered by this patent

fostemsavir-tromethamine (FOSTEMSAVIR TROMETHAMINE)

Patent Metadata

Patent number: CN101941990B
Jurisdiction: CN
Classification: —
Expires: 2012-04-25
Drug substance claim: No
Drug product claim: No
Assignee: Bristol Myers Squibb Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.